NON-HODGKIN^S LYMPHOMA REFRACTORY

This adverse event was reported 0 times

These drugs are most commonly taken by patients reporting NON-HODGKIN^S LYMPHOMA REFRACTORY:

# Drug Count
See all common drugs associated with NON-HODGKIN^S LYMPHOMA REFRACTORY

NON-HODGKIN^S LYMPHOMA REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
See all drugs enriched for association with NON-HODGKIN^S LYMPHOMA REFRACTORY

These drug classes are most commonly taken by patients reporting NON-HODGKIN^S LYMPHOMA REFRACTORY:

# Drug class Count
See all common drug classes associated with NON-HODGKIN^S LYMPHOMA REFRACTORY

NON-HODGKIN^S LYMPHOMA REFRACTORY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
See all drug classes enriched for association with NON-HODGKIN^S LYMPHOMA REFRACTORY